Skip to main content
Erschienen in: Indian Journal of Surgical Oncology 2/2020

10.05.2020 | Original Article

Gastrectomy with D2 Lymphadenectomy for Carcinoma of the Stomach in a Stand-alone Cancer Centre in Rural India

verfasst von: Nizamudheen Mangalasseri Pareekutty, Sachin Kadam, Basavaraj Ankalkoti, Satheesan Balasubramanian, Bindu Anilkumar

Erschienen in: Indian Journal of Surgical Oncology | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Context

The therapeutic role of D2 lymphadenectomy in the management of gastric cancer is an ongoing controversy.

Aims

To examine the morbidity and oncological outcomes of D2 lymph node dissection for gastric cancer patients treated in a stand-alone cancer center in rural India and to compare it with international data.

Settings and Design

Retrospective study on patients treated for gastric cancer from June 2009 to December 2014.

Methods and Material

All patients underwent subtotal or total gastrectomy with modified D2 lymph node dissection preserving spleen and pancreas. The Clavien-Dindo model was used to stratify the severity of morbidity.

Statistical analysis

Descriptive statistics was used for data exploration. Chi-square test was used to compare the association of various factors with survival. Kaplan-Meier method was used to calculate the survival rates (RFS and DFS). Log-rank test was used to compare the survival of different subgroups.

Results

Fifty-four patients (41 males and 13 females) were included in the study. Four (7.4%) patients had significant postoperative morbidity. The 5-year OS and DFS respectively were 34.9% and 37.6%. Female sex was associated with poorer survival. Lymph node ratio of more than 0.2 and advanced stage at presentation showed strong tendency towards lower OS and DFS.

Conclusions

An R0 resection with D2 lymphadenectomy for gastric cancer carries acceptable morbidity and mortality in Indian patients with survival rates comparable with the western studies. Lymph node ratio more than 0.2 and female gender and advanced stage were associated with poorer oncological outcomes.
Literatur
2.
Zurück zum Zitat Globocon 2012 (IARC), Section of cancer surveillance (28/12/2016) Stomach cancer estimated incidence, mortality and prevalence worldwide in 2012 Globocon 2012 (IARC), Section of cancer surveillance (28/12/2016) Stomach cancer estimated incidence, mortality and prevalence worldwide in 2012
3.
Zurück zum Zitat Indian Council of Medical Research. Consensus document for management of gastric cancer 2014, chapter1; pp.1 Indian Council of Medical Research. Consensus document for management of gastric cancer 2014, chapter1; pp.1
4.
Zurück zum Zitat Bonenkamp J, Songun I, Hermans J, Sasako M, Welvaart K, Plukker JT, van Elk P, Obertop H, Gouma DJ, Taat CW (1995) Randomized comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 345(8952):745–748CrossRef Bonenkamp J, Songun I, Hermans J, Sasako M, Welvaart K, Plukker JT, van Elk P, Obertop H, Gouma DJ, Taat CW (1995) Randomized comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 345(8952):745–748CrossRef
5.
Zurück zum Zitat Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, Cook P (1996) Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Lancet 347(9007):995–999CrossRef Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, Cook P (1996) Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Lancet 347(9007):995–999CrossRef
6.
Zurück zum Zitat Kavaliauskas P, Maziukas R, Samalavicius NE, Kuliavas J, Lunevicius R (2016) Subtotal gastrectomy with conventional D2 lymphadenectomy for carcinoma of the distal gastric portion: a retrospective cohort study on clinical outcome. Ann Med Surg (Lond) 6:36–41CrossRef Kavaliauskas P, Maziukas R, Samalavicius NE, Kuliavas J, Lunevicius R (2016) Subtotal gastrectomy with conventional D2 lymphadenectomy for carcinoma of the distal gastric portion: a retrospective cohort study on clinical outcome. Ann Med Surg (Lond) 6:36–41CrossRef
7.
Zurück zum Zitat Roviello F, Marrelli D, Morgagni P, de Manzoni G, di Leo A, Vindigni C, Saragoni L, Tomezzoli A, Kurihara H, Italian Research Group for Gastric Cancer (2002) Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: a longitudinal multicenter study. Ann Surg Oncol 9(9):894–900CrossRef Roviello F, Marrelli D, Morgagni P, de Manzoni G, di Leo A, Vindigni C, Saragoni L, Tomezzoli A, Kurihara H, Italian Research Group for Gastric Cancer (2002) Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: a longitudinal multicenter study. Ann Surg Oncol 9(9):894–900CrossRef
8.
Zurück zum Zitat Biffi R, Chiappa A, Luca F et al (2006) Extended lymph node dissection without routine spleno-pancreatectomy for treatment of gastric cancer: low morbidity and mortality rates in a single centre series of 250 patients. J Surg Oncol 93(5):394–400CrossRef Biffi R, Chiappa A, Luca F et al (2006) Extended lymph node dissection without routine spleno-pancreatectomy for treatment of gastric cancer: low morbidity and mortality rates in a single centre series of 250 patients. J Surg Oncol 93(5):394–400CrossRef
9.
Zurück zum Zitat Maruyama K, Okabayashi K, Kinoshita T (1987) Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 11:418–425CrossRef Maruyama K, Okabayashi K, Kinoshita T (1987) Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 11:418–425CrossRef
10.
Zurück zum Zitat Noguchi M, Miyazakit I (1996) Prognostic significance and surgical management of lymph node metastasis in gastric cancer. Br J Surg 83:156–161CrossRef Noguchi M, Miyazakit I (1996) Prognostic significance and surgical management of lymph node metastasis in gastric cancer. Br J Surg 83:156–161CrossRef
11.
Zurück zum Zitat Park DJ, Lee HJ, Kim HH et al (2005) Predictors of operative morbidity and mortality in gastric cancer surgery. Br J Surg 92:1099–1102CrossRef Park DJ, Lee HJ, Kim HH et al (2005) Predictors of operative morbidity and mortality in gastric cancer surgery. Br J Surg 92:1099–1102CrossRef
12.
Zurück zum Zitat Hartgritik HH, Van de Velde CJH, Putter H et al (2004) Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch Gastric Cancer Group trial. J Clin Oncol 22(11):2069–2077CrossRef Hartgritik HH, Van de Velde CJH, Putter H et al (2004) Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch Gastric Cancer Group trial. J Clin Oncol 22(11):2069–2077CrossRef
13.
Zurück zum Zitat Bunt AMG, Hermans J, Boon MC, van de Velde C, Sasako M, Fleuren GJ, Bruijn JA (1994) Evaluation of the extent of lymphadenectomy in a randomized trial of Western- versus Japanese-type surgery in gastric cancer. J Clin Oncol 12(2):417–422CrossRef Bunt AMG, Hermans J, Boon MC, van de Velde C, Sasako M, Fleuren GJ, Bruijn JA (1994) Evaluation of the extent of lymphadenectomy in a randomized trial of Western- versus Japanese-type surgery in gastric cancer. J Clin Oncol 12(2):417–422CrossRef
14.
Zurück zum Zitat Songun I, Putter H, Kranenbarg EMK, Sasako M, Van de Velde CJH (2010) Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 11(5):439–449CrossRef Songun I, Putter H, Kranenbarg EMK, Sasako M, Van de Velde CJH (2010) Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 11(5):439–449CrossRef
15.
Zurück zum Zitat Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P (1999) Patient survival after D1 and D2 dissections for gastric cancer: long-term results of the MRC randomized surgical trial surgical cooperative group. Br J Cancer 79:1522–1530CrossRef Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P (1999) Patient survival after D1 and D2 dissections for gastric cancer: long-term results of the MRC randomized surgical trial surgical cooperative group. Br J Cancer 79:1522–1530CrossRef
16.
Zurück zum Zitat Reis E, Kama NA, Doganay M, Atli M, Dolapci M (2002) Long-term survival is improved by an extended lymph node dissection in potentially curable gastric cancer. Hepatogastroenterology 49:1167–1171PubMed Reis E, Kama NA, Doganay M, Atli M, Dolapci M (2002) Long-term survival is improved by an extended lymph node dissection in potentially curable gastric cancer. Hepatogastroenterology 49:1167–1171PubMed
17.
Zurück zum Zitat Brennan MF (2005) Current status of surgery for gastric cancer: a review. Gastric Cancer 8:64–70CrossRef Brennan MF (2005) Current status of surgery for gastric cancer: a review. Gastric Cancer 8:64–70CrossRef
18.
Zurück zum Zitat Degiuli M, Sasako M, Calgaro M, Garino M, Rebecchi F, Mineccia M, Scaglione D, Andreone D, Ponti A, Calvo F, Italian Gastric Cancer Study Group (2004) Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. Eur J Surg Oncol 30:303–308CrossRef Degiuli M, Sasako M, Calgaro M, Garino M, Rebecchi F, Mineccia M, Scaglione D, Andreone D, Ponti A, Calvo F, Italian Gastric Cancer Study Group (2004) Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. Eur J Surg Oncol 30:303–308CrossRef
19.
Zurück zum Zitat Degiuli M, Sasako M, Ponti A, Vendrame A, Tomatis M, Mazza C, Borasi A, Capussotti L, Fronda G, Morino M, Italian Gastric Cancer Study Group (2014) Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer. Br J Surg 101(2):23–31CrossRef Degiuli M, Sasako M, Ponti A, Vendrame A, Tomatis M, Mazza C, Borasi A, Capussotti L, Fronda G, Morino M, Italian Gastric Cancer Study Group (2014) Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer. Br J Surg 101(2):23–31CrossRef
21.
Zurück zum Zitat Memon MA, Subramanya MS, Khan S, Hossain MB, Osland E, Memon B (2011) Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma. Ann Surg 253:900–911CrossRef Memon MA, Subramanya MS, Khan S, Hossain MB, Osland E, Memon B (2011) Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma. Ann Surg 253:900–911CrossRef
22.
Zurück zum Zitat Strong VE, Song KY, Park CH et al (2010) Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann Surg 251:640–646CrossRef Strong VE, Song KY, Park CH et al (2010) Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann Surg 251:640–646CrossRef
23.
Zurück zum Zitat Komatsu S, Ichikawa D, Nishimura M, Kosuga T, Okamoto K, Konishi H, Shiozaki A, Fujiwara H, Otsuji E (2017) Evaluation of prognostic value and stage migration effect using positive lymph node ratio in gastric cancer. Eur J Surg Oncol 43:203–209CrossRef Komatsu S, Ichikawa D, Nishimura M, Kosuga T, Okamoto K, Konishi H, Shiozaki A, Fujiwara H, Otsuji E (2017) Evaluation of prognostic value and stage migration effect using positive lymph node ratio in gastric cancer. Eur J Surg Oncol 43:203–209CrossRef
24.
Zurück zum Zitat Melis M, Masi A, Pinna A, Cohen S, Hatzaras I, Berman R, Pachter LH, Newman E (2015) Does lymph node ratio affect prognosis in gastroesophageal cancer? Am J Surg 210:443–450CrossRef Melis M, Masi A, Pinna A, Cohen S, Hatzaras I, Berman R, Pachter LH, Newman E (2015) Does lymph node ratio affect prognosis in gastroesophageal cancer? Am J Surg 210:443–450CrossRef
25.
Zurück zum Zitat De Angelis R, Sant M, Coleman MP et al (2014) Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5 a population-based study. Lancet Oncol 15:23–34CrossRef De Angelis R, Sant M, Coleman MP et al (2014) Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5 a population-based study. Lancet Oncol 15:23–34CrossRef
26.
Zurück zum Zitat Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, et al. SEER cancer statistics review, 1975-2014, National Cancer Institute. Bethesda, https://seer.cancer.gov/csr/1975_2014/, based on November 2016 SEER data submission, posted to the SEER web site, April 2017 Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, et al. SEER cancer statistics review, 1975-2014, National Cancer Institute. Bethesda, https://​seer.​cancer.​gov/​csr/​1975_​2014/​, based on November 2016 SEER data submission, posted to the SEER web site, April 2017
27.
Zurück zum Zitat Wu CW, Hsiung CA, Lo SS, Hsieh MC, Shia LT, Whang-Peng J (2004) Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer. Br J Surg 91(3):283–287CrossRef Wu CW, Hsiung CA, Lo SS, Hsieh MC, Shia LT, Whang-Peng J (2004) Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer. Br J Surg 91(3):283–287CrossRef
28.
Zurück zum Zitat Shrikhande SV, Shukla PJ, Qureshi S, Siddachari R, Upasani V, Ramadwar M, Kakade AC, Hawaldar R (2006) D2 lymphadenectomy for gastric cancer in Tata Memorial Hospital: Indian data can now be incorporated in future international trials. Dig Surg 23:192–197CrossRef Shrikhande SV, Shukla PJ, Qureshi S, Siddachari R, Upasani V, Ramadwar M, Kakade AC, Hawaldar R (2006) D2 lymphadenectomy for gastric cancer in Tata Memorial Hospital: Indian data can now be incorporated in future international trials. Dig Surg 23:192–197CrossRef
Metadaten
Titel
Gastrectomy with D2 Lymphadenectomy for Carcinoma of the Stomach in a Stand-alone Cancer Centre in Rural India
verfasst von
Nizamudheen Mangalasseri Pareekutty
Sachin Kadam
Basavaraj Ankalkoti
Satheesan Balasubramanian
Bindu Anilkumar
Publikationsdatum
10.05.2020
Verlag
Springer India
Erschienen in
Indian Journal of Surgical Oncology / Ausgabe 2/2020
Print ISSN: 0975-7651
Elektronische ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-020-01059-w

Weitere Artikel der Ausgabe 2/2020

Indian Journal of Surgical Oncology 2/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.